ISSUE 1471
| The full article is available to subscribers | Subscriber Login |
An article published in the New York Times on May 1, 2015 listed the 10 drugs on which Medicare Part D spent the most in 2013. The most costly ($2.53 billion) was the proton pump inhibitor (PPI) Nexium (esomeprazole magnesium), which has recently become available generically.
EFFICACY AND TOLERABILITY – PPIs are effective in relieving symptoms of gastroesophageal reflux disease (GERD) and in healing erosive esophagitis and peptic ulcers, and they are generally well tolerated. There is no convincing evidence that any one PPI is more effective or better tolerated than any other.1,2
DRUG INTERACTIONS – Omeprazole and esomeprazole are inhibitors of CYP2C19 and can increase serum concentrations of drugs metabolized by this pathway, such as diazepam (Valium, and generics) and phenytoin (Dilantin, and others). They can
... more- Drugs for peptic ulcer disease and GERD. Treat Guidel Med Lett 2014; 12:25.
- PO Katz et al. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013; 108:308.
- LB Gerson. Proton pump inhibitors and potential interactions with clopidogrel: an update. Curr Gastroenterol Rep 2013; 15:329.
- SD Bouziana and K Tziomalos. Clinical relevance of clopidogrel-proton pump inhibitors interaction. World J Gastrointest Pharmacol Ther 2015; 6:17.
Would you like to read the rest of this article? Gain access below.
- Print version published and mailed biweekly (26 issues/year)
- Immediate Online access to current issue and archives from 1988 to the present
- Mobile access to our mobile site and free apps for iOS, Android and Kindle
- FREE online per issue CME/CE
